Variant Summary
- Also known as
- T(2;17)(P23;Q23),CLTC-ALK
- HGVS
- —
- Variant Type(s)
- transcript_fusion
- Evidence Items
- 3
Evidence Level Distribution
Level C: 2Level D: 1
Evidence Items
Showing CIViC evidence rows where gene = CLTC::ALK and variant = Fusion.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Diffuse Large B-cell Lymphoma | ALK Inhibitor TAE684 | 4 |
| C | Prognostic | Supports | Poor Outcome | Diffuse Large B-cell Lymphoma | 3 | |
| C | Predictive | Supports | Sensitivity/Response | Diffuse Large B-cell Lymphoma | Crizotinib | 3 |